Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter G Rose

Showing results (101-110 of 201) with videos related to

Pageof 21
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 12, 2015
Postoperative Complications After Distal Pancreatectomy Performed During Cytoreductive Surgery for Gynecologic MalignanciesHaider Mahdi, Peter G Rose, Samantha Gonzalez, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|September 10, 2015
Prostate-Type Adenocarcinoma in Mature Cystic Ovarian TeratomaJamie Stanhiser, Haider Mahdi, Gabriela Rosa, et al.
Gynecologic Oncology Reports|August 17, 2021
Lenvatinib plus pembrolizumab in patients with advanced or recurrent uterine carcinosarcomaJonathan T Hunt, Laura M Chambers, Meng Yao, et al.
American Journal of Obstetrics and Gynecology|May 19, 2015
Referring survivors of endometrial cancer and complex atypical hyperplasia to bariatric specialists: a prospective cohort studyAmelia M Jernigan, Kathryn A Maurer, Karen Cooper, et al.
NPJ Precision Oncology|December 18, 2021
High TGF-β signature predicts immunotherapy resistance in gynecologic cancer patients treated with immune checkpoint inhibitionYing Ni, Ahmed Soliman, Amy Joehlin-Price, et al.
Gynecologic Oncology|July 21, 2004
Evaluation of concurrent and adjuvant carboplatin with radiation therapy for locally advanced cervical cancerRachel A Dubay, Peter G Rose, David M O'Malley, et al.
Gynecologic Oncology|August 26, 2014
Locally advanced adenocarcinoma and adenosquamous carcinomas of the cervix compared to squamous cell carcinomas of the cervix in gynecologic oncology group trials of cisplatin-based chemoradiationPeter G Rose, James J Java, Charles W Whitney, et al.
Journal of Gynecologic Oncology|January 23, 2026
Gram-positive targeting antibiotics are associated with progression and death in women with platinum-sensitive recurrent high grade epithelial ovarian cancerLaura M Chambers, Julia Chalif, Meng Yao, et al.
Gynecologic Oncology|May 23, 2006
Phase II study of oxaliplatin as second-line chemotherapy in endometrial carcinoma: a Gynecologic Oncology Group studyPaula M Fracasso, John A Blessing, Kelly L Molpus, et al.
Gynecologic Oncology|February 15, 2003
A phase II study of docetaxel in paclitaxel-resistant ovarian and peritoneal carcinoma: a Gynecologic Oncology Group studyPeter G Rose, John A Blessing, Harrison G Ball, et al.
Pageof 21

Showing results (101-110 of 201) with videos related to

Sort By:
Pageof 21
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 12, 2015
Postoperative Complications After Distal Pancreatectomy Performed During Cytoreductive Surgery for Gynecologic MalignanciesHaider Mahdi, Peter G Rose, Samantha Gonzalez, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|September 10, 2015
Prostate-Type Adenocarcinoma in Mature Cystic Ovarian TeratomaJamie Stanhiser, Haider Mahdi, Gabriela Rosa, et al.
Gynecologic Oncology Reports|August 17, 2021
Lenvatinib plus pembrolizumab in patients with advanced or recurrent uterine carcinosarcomaJonathan T Hunt, Laura M Chambers, Meng Yao, et al.
American Journal of Obstetrics and Gynecology|May 19, 2015
Referring survivors of endometrial cancer and complex atypical hyperplasia to bariatric specialists: a prospective cohort studyAmelia M Jernigan, Kathryn A Maurer, Karen Cooper, et al.
NPJ Precision Oncology|December 18, 2021
High TGF-β signature predicts immunotherapy resistance in gynecologic cancer patients treated with immune checkpoint inhibitionYing Ni, Ahmed Soliman, Amy Joehlin-Price, et al.
Gynecologic Oncology|July 21, 2004
Evaluation of concurrent and adjuvant carboplatin with radiation therapy for locally advanced cervical cancerRachel A Dubay, Peter G Rose, David M O'Malley, et al.
Gynecologic Oncology|August 26, 2014
Locally advanced adenocarcinoma and adenosquamous carcinomas of the cervix compared to squamous cell carcinomas of the cervix in gynecologic oncology group trials of cisplatin-based chemoradiationPeter G Rose, James J Java, Charles W Whitney, et al.
Journal of Gynecologic Oncology|January 23, 2026
Gram-positive targeting antibiotics are associated with progression and death in women with platinum-sensitive recurrent high grade epithelial ovarian cancerLaura M Chambers, Julia Chalif, Meng Yao, et al.
Gynecologic Oncology|May 23, 2006
Phase II study of oxaliplatin as second-line chemotherapy in endometrial carcinoma: a Gynecologic Oncology Group studyPaula M Fracasso, John A Blessing, Kelly L Molpus, et al.
Gynecologic Oncology|February 15, 2003
A phase II study of docetaxel in paclitaxel-resistant ovarian and peritoneal carcinoma: a Gynecologic Oncology Group studyPeter G Rose, John A Blessing, Harrison G Ball, et al.
Pageof 21